OTLK NASDAQ
Outlook Therapeutics, Inc.
1W: -7.3%
1M: -5.3%
3M: -58.2%
YTD: -10.2%
1Y: -43.0%
3Y: -86.3%
5Y: -98.7%
$0.59
+0.02 (+3.13%)
Weekly Expected Move ±7.9%
$0
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$-1M
Revenue
-169.4% YoY
$-61M
Net Income
-40.7% YoY
$-57M
Free Cash Flow
-1.2% YoY
-88.9%
Gross Margin
-120111.1%
Op. Margin
-225766.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE256.9%
ROA-251.7%
ROIC1372.0%
Valuation
P/E-0.3
P/B-1.5
EV/EBITDA-0.8
Leverage
Debt/Equity-1.77
Current Ratio0.81
Interest Cov.-236.1x
Quality Scores
Piotroski F4/9
Altman Z-42.44
Beneish M116.82